Identifying new substances to improve vaccine effectiveness.
TO IDENTIFY NOVEL ADJUVANT CANDIDATES THAT CAN BE USED TO AUGMENT THE EFFICACY OF HUMAN VACCINES.
['FUNDING_OTHER'] · UNIVERSITY OF CALIFORNIA, SAN DIEGO · NIH-11074014
This study is looking for new ways to boost how well vaccines work by testing different substances that can help your immune system respond better, which could lead to stronger and longer-lasting protection against diseases.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF CALIFORNIA, SAN DIEGO (nih funded) |
| Locations | 1 site (LA JOLLA, UNITED STATES) |
| Trial ID | NIH-11074014 on ClinicalTrials.gov |
What this research studies
This research focuses on discovering new adjuvants, which are substances that can enhance the body's immune response to vaccines. By exploring how these adjuvants can stimulate both the innate and adaptive immune systems, the research aims to improve the efficacy of vaccines, potentially leading to better protection against diseases. Patients may benefit from vaccines that provide stronger and longer-lasting immunity due to these novel adjuvants. The approach involves laboratory experiments to test various candidates and their effects on immune cells.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research include individuals receiving vaccinations, particularly those at higher risk for infectious diseases.
Not a fit: Patients who are not receiving vaccinations or those with conditions that prevent them from being vaccinated may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to vaccines that offer improved protection against infectious diseases.
How similar studies have performed: Other research has shown promise in enhancing vaccine efficacy through novel adjuvants, indicating that this approach has potential for success.
Where this research is happening
LA JOLLA, UNITED STATES
- UNIVERSITY OF CALIFORNIA, SAN DIEGO — LA JOLLA, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: CARSON, DENNIS — UNIVERSITY OF CALIFORNIA, SAN DIEGO
- Study coordinator: CARSON, DENNIS
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.